Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) trades at $25.58 with AI Score 44/100 (Grade C). Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) invests primarily in equity securities of companies in or… Market cap: $3.21B, Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for IPOAX: IPOAX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IPOAX against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
IPOAX: 1/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) Financial Services Profile
Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) offers investors exposure to emerging market equities through a systematic investment approach. With a focus on long-term capital appreciation, the fund allocates at least 80% of its assets to companies in or linked to emerging economies, providing diversification within the financial services sector.
What Is the Investment Thesis for IPOAX?
Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) presents an investment opportunity centered on exposure to emerging market equities. The fund's systematic approach aims to capture long-term capital appreciation by investing at least 80% of its net assets in companies in or linked to emerging economies. A key value driver is the growth potential of emerging markets, which are expected to outpace developed markets in the coming years. Catalysts include increasing foreign investment in emerging markets and the rise of a consumer class in these regions. However, potential risks include economic and political instability in emerging markets, currency fluctuations, and the fund's beta of 0.92, indicating moderate volatility relative to the market.
Based on FMP financials and quantitative analysis
IPOAX Key Highlights
The fund invests at least 80% of its net assets in equity securities of companies in or linked to emerging market countries.
- IPOAX may invest up to 100% of its total assets in foreign securities, providing broad exposure to global emerging markets.
- The fund has a market capitalization of $3.21B, indicating its significance within the emerging markets equity fund landscape.
- IPOAX has a beta of 0.92, suggesting moderate volatility compared to the overall market.
- The fund does not offer a dividend yield, focusing instead on capital appreciation.
Who Are IPOAX's Competitors?
IPOAX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BBHLX BBH Partner Fund - International Equity Class Institutional | $23.39 | +0.47% | $2.61B | 44 |
| BFGFX Baron Focused Growth Fund Retail Shs | $62.02 | -1.51% | $3.10B | 47 |
| BFGIX Baron Focused Growth Fund Inst Shs | $65.26 | -1.51% | $3.10B | 47 |
| JORNX Janus Henderson Global Select Fund - T Shares | $21.71 | +0.00% | $2.73B | 46 |
| JORRX Janus Henderson Global Select Fund Class R | $21.06 | -0.05% | $2.65B | 46 |
| HTGC Hercules Capital, Inc. | $17.03 | +0.77% | $3.19B | 70 |
| AAMI Acadian Asset Management (AAMI) | $90.85 | -0.21% | $3.24B | 84 |
| SII Sprott Inc. | $126.56 | +4.73% | $3.26B | 71 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IPOAX's Key Strengths?
Exposure to high-growth emerging markets.
- Systematic investment approach.
- Experienced management team.
- Diversified portfolio.
What Are IPOAX's Weaknesses?
Higher volatility compared to developed markets.
- Exposure to political and economic instability in emerging markets.
- Currency risk.
- Dependence on emerging market performance.
What Could Drive IPOAX Stock Higher?
Continued growth in emerging market economies.
- Increasing foreign investment in emerging markets.
- Rise of a consumer class in emerging markets.
- Potential policy reforms in emerging market countries that could boost economic growth.
- Technological advancements driving innovation in emerging markets.
What Are the Key Risks for IPOAX?
Economic and political instability in emerging markets.
- Currency fluctuations.
- Geopolitical risks.
- Increased competition in the asset management industry.
- Market volatility affecting emerging market equities.
What Are the Growth Opportunities for IPOAX?
- Expansion into New Emerging Markets: IPOAX can explore new emerging markets with high growth potential, such as frontier markets in Africa and Southeast Asia. These markets offer untapped investment opportunities and diversification benefits. The market size for frontier markets is estimated to reach $1 trillion by 2030, presenting a significant growth avenue for the fund. Timeline: Within the next 3-5 years.
- Increased Allocation to Technology and Innovation: Emerging markets are witnessing rapid technological advancements, particularly in areas like fintech, e-commerce, and artificial intelligence. IPOAX can increase its allocation to companies driving these innovations, capitalizing on the growth of the digital economy in emerging markets. The market size for digital technologies in emerging markets is projected to reach $500 billion by 2028. Timeline: Ongoing.
- Focus on Sustainable and Responsible Investing: There is a growing demand for sustainable and responsible investing in emerging markets, driven by increasing awareness of environmental, social, and governance (ESG) issues. IPOAX can integrate ESG factors into its investment process and target companies with strong sustainability practices, attracting socially conscious investors. The market size for ESG investing in emerging markets is expected to reach $2 trillion by 2027. Timeline: Ongoing.
- Development of Thematic Investment Products: IPOAX can develop thematic investment products focused on specific trends in emerging markets, such as urbanization, infrastructure development, and healthcare. These thematic products can cater to investors seeking targeted exposure to specific growth drivers in emerging economies. The market size for thematic investing in emerging markets is projected to reach $1.5 trillion by 2029. Timeline: Within the next 2-4 years.
- Enhancement of Distribution Channels: IPOAX can expand its distribution channels by partnering with local financial institutions and wealth managers in emerging markets. This will increase the fund's accessibility to a wider range of investors and drive asset growth. The market size for asset management in emerging markets is expected to reach $10 trillion by 2028, presenting a significant opportunity for IPOAX to expand its reach. Timeline: Ongoing.
What Threats Does IPOAX Face?
- Increased competition from other emerging market funds.
- Geopolitical risks.
- Changes in government regulations.
- Economic slowdown in emerging markets.
What Are IPOAX's Competitive Advantages?
- Established track record in emerging market investing.
- Systematic investment approach based on proprietary research.
- Experienced investment management team.
- Diversified portfolio across multiple emerging market countries and sectors.
What Does IPOAX Do?
Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) is an actively managed fund focused on providing investors with exposure to the growth potential of emerging markets. The fund invests primarily in equity securities, with a significant emphasis on common stock, of companies located in or economically tied to emerging market countries. Under normal circumstances, at least 80% of the fund's net assets are allocated to these investments. The fund's strategy allows for investment in depositary receipts of foreign issuers and permits up to 100% of its total assets to be held in foreign securities, showcasing a global investment approach within the emerging markets sphere. Furthermore, the fund retains the flexibility to invest up to 20% of its net assets in companies not directly associated with emerging markets, providing a degree of diversification beyond its primary focus. IPOAX operates within the asset management industry, catering to investors seeking long-term capital appreciation through exposure to the dynamic economies of emerging markets. The fund's systematic approach aims to identify and capitalize on opportunities within these markets, while also managing risk through diversification and active portfolio management. IPOAX, with its $3.21B market capitalization, is a significant player in the emerging markets equity fund space.
What Products and Services Does IPOAX Offer?
- Invests in equity securities of companies in emerging market countries.
- Focuses primarily on common stock.
- May invest in depositary receipts of foreign issuers.
- Can allocate up to 100% of its assets in foreign securities.
- May invest up to 20% of its net assets in companies not linked to emerging markets.
- Aims for long-term capital appreciation.
How Does IPOAX Make Money?
- Generates revenue through management fees based on assets under management (AUM).
- May earn performance-based fees if the fund outperforms its benchmark.
- Invests in equity securities to generate capital gains.
- Reinvests dividends and other income to enhance returns.
What Industry Does IPOAX Operate In?
Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) operates within the asset management industry, specifically targeting emerging markets equities. The industry is characterized by increasing demand for emerging market investments, driven by the potential for higher growth compared to developed economies. The competitive landscape includes funds such as BBHLX (BlackRock Health Sciences Opportunities Portfolio Investor A), BFGFX (BlackRock Global Allocation Fund Investor A), BFGIX (BlackRock Global Allocation Fund Institutional), JORNX (JPMorgan US Research Enhanced Equity Fund Class R6), and JORRX (JPMorgan US Research Enhanced Equity Fund Class R5), each with varying investment strategies and focuses. IPOAX differentiates itself through its systematic investment approach and focus on long-term capital appreciation.
Who Are IPOAX's Key Customers?
- Institutional investors seeking exposure to emerging market equities.
- Retail investors looking for long-term capital appreciation.
- Financial advisors seeking diversified investment options for their clients.
- Pension funds and endowments investing in emerging markets.
Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) Valuation Context
Relative to its peer group, IPOAX's quantitative score of 44/100 is roughly in line with the peer average of 46/100.
IPOAX Financials
Bull Case vs Bear Case
Bull Case
- Exposure to high-growth emerging markets.
- Systematic investment approach.
- Experienced management team.
- Diversified portfolio.
Bear Case
- Higher volatility compared to developed markets.
- Exposure to political and economic instability in emerging markets.
- Currency risk.
- Dependence on emerging market performance.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
IPOAX Latest News
No recent news available for IPOAX.
IPOAX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IPOAX.
Price Targets
Wall Street price target analysis for IPOAX.
IPOAX MoonshotScore
What does this score mean?
The MoonshotScore rates IPOAX 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Macquarie Systematic Emerging Markets Equity Fund A Financial Services Stock: Key Questions Answered
What does the AI Score mean for IPOAX?
IPOAX holds an AI Score of 44/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) invests primarily in equity securities of companies in or linked to emerging markets. The fund aims to provide long-term capital …
What does Macquarie Systematic Emerging Markets Equity Fund A do?
Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) is designed to provide investors with exposure to the equity markets of emerging economies. The fund operates by investing at least 80% of its net assets in equity securities, primarily common stock, of companies located in or economically linked to emerging market countries.
What do analysts say about IPOAX stock?
As of 2026-03-18, AI analysis for IPOAX is pending, so there is no current analyst consensus available. However, it is important to consider the fund's investment strategy, which focuses on emerging market equities. Emerging markets offer potential for high growth but also come with increased volatility and risk.
What are the main risks for IPOAX?
The main risks for Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) are inherent to investing in emerging markets. These include economic and political instability, currency fluctuations, and geopolitical risks. Emerging markets can be more volatile than developed markets, leading to potentially larger price swings.
How does Macquarie Systematic Emerging Markets Equity Fund A make money in financial services?
Macquarie Systematic Emerging Markets Equity Fund A generates revenue primarily through management fees, which are calculated as a percentage of the fund's assets under management (AUM). These fees compensate the fund's manager for their expertise in selecting and managing the fund's investments.
What is Macquarie Systematic Emerging Markets Equity Fund A's approach to managing risk in emerging markets?
Macquarie Systematic Emerging Markets Equity Fund A employs several strategies to manage risk in emerging markets. Diversification is a key component, as the fund invests in a broad range of companies across different sectors and countries within the emerging market universe. This helps to mitigate the impact of any single company or country's underperformance.
What are the key factors to evaluate for IPOAX?
Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) holds an AI score of 44/100 (low). Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) presents an investment opportunity centered on exposure to emerging market equities. Not financial advice.
How frequently does IPOAX data refresh on this page?
IPOAX's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven IPOAX's recent stock price performance?
Macquarie Systematic Emerging Markets Equity Fund A (IPOAX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Exposure to high-growth emerging markets. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The information provided is based on available data and may be subject to change.
- AI analysis is pending and may provide further insights into the fund's performance and risk factors.